| Identification | Back Directory | [Name]
C16 (2'(S)-hydroxy) Ceramide (d18:1/16:0) | [CAS]
890041-50-6 | [Synonyms]
C16 (2&rsquo
16:0(2S-OH) Ceramide
(S)-hydroxy) Ceramide (d18:1/16:0)
C16 (2'(S)-hydroxy) Ceramide (d18:1/16:0)
Hexadecanamide, 2-hydroxy-N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-, (2S)- | [Molecular Formula]
C34H67NO4 | [MDL Number]
MFCD22416672 | [MOL File]
890041-50-6.mol | [Molecular Weight]
553.9 |
| Chemical Properties | Back Directory | [storage temp. ]
-20°C | [solubility ]
DMF: 10 mg/ml; DMSO: 2 mg/ml; Ethanol: miscible | [form ]
A crystalline solid | [InChIKey]
YWZGQPJRQXHVQX-UMKNRRHWSA-N | [SMILES]
CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](NC([C@@H](O)CCCCCCCCCCCCCC)=O)CO |
| Hazard Information | Back Directory | [Description]
C16 (2'(S)-hydroxy) Ceramide is the synthetic ceramide stereoisomer of N-(2'-(R)-hydroxypalmitoyl)-D-erythro-sphingosine.1 C16 (2'(S)-hydroxy) Ceramide is the less active isomer, having no effect on C6 glioma cell viability at concentrations up to 20 μM. | [Uses]
C16 (2'(S)-Hydroxy) ceramide (d18:1/16:0) is a biochemical reagent. | [References]
1. Kota, V., Dhople, V.M., Fullbright, G., et al. 2'-hydroxy C16-ceramide induces apoptosis-associated proteomic changes in C6 glioma cells J. Proteome Res. 12(10),4366-4375(2013). |
|
|